Home / Pharma Healthcare / Prostate Cancer Market to 2022 - Increasing Disease Prevalence to be a Key Driver of Market Growth

Prostate Cancer Market to 2022 - Increasing Disease Prevalence to be a Key Driver of Market Growth

  • Id : RNR-533366
  • Category : Pharma Healthcare
  • Publish Date : Apr 2019
  • Pages : 125
  • Format : PDF
License Type

Description
This report analyzes the worldwide markets for Prostate Cancer Therapeutics in US$ Million by the following Segments: Hormone Therapy, and Other Therapies. The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 76 companies including many key and niche players such as - 

AbbVie, Inc.
Allergan plc
Amgen, Inc. 
Astellas Pharma, Inc.
AstraZeneca Plc
Bayer AG

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location. 

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report. 

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.